Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Raciran 150 tablets
0103010T0BEAAAA
|
Raciran | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Raciran 300 tablets
0103010T0BEABAC
|
Raciran | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Raft-Eze liquid
0101021B0BLAAAH
|
Raft-Eze | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Ranicalm 75mg tablets
0103010T0BWAAAP
|
Ranicalm | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitic 150mg tablets
0103010T0BHAAAA
|
Ranitic | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitic 300mg tablets
0103010T0BHABAC
|
Ranitic | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 1.5mg/5ml oral liquid
0103010T0AAAZAZ
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 1.8mg/5ml oral liquid
0103010T0AABIBI
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 11.4mg/5ml oral liquid
0103010T0AABPBP
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 12mg/5ml oral liquid
0103010T0AABNBN
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 16mg/5ml oral liquid
0103010T0AABEBE
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 18mg/5ml oral liquid
0103010T0AABDBD
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 1mg/5ml oral solution
0103010T0AABTBT
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 20mg/5ml oral liquid
0103010T0AABCBC
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 25mg/5ml oral liquid
0103010T0AAATAT
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 30mg/5ml oral liquid
0103010T0AAAWAW
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 31mg/5ml oral liquid
0103010T0AAAVAV
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 37.5mg/5ml oral solution
0103010T0AABVBV
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 3mg/5ml oral liquid
0103010T0AABHBH
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 40mg/5ml oral liquid
0103010T0AABBBB
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 4mg/5ml oral liquid
0103010T0AAARAR
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 50mg/5ml oral liquid
0103010T0AAASAS
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 6mg/5ml oral solution
0103010T0AABSBS
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 70mg/5ml oral liquid
0103010T0AAAXAX
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 75mg effervescent tablets sugar free
0103010T0AABKBK
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.